Tunsirikongkon, A.; Pyo, Y.-C.; Kim, D.-H.; Lee, S.-E.; Park, J.-S.
Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug. Pharmaceutics 2019, 11, 272.
https://doi.org/10.3390/pharmaceutics11060272
AMA Style
Tunsirikongkon A, Pyo Y-C, Kim D-H, Lee S-E, Park J-S.
Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug. Pharmaceutics. 2019; 11(6):272.
https://doi.org/10.3390/pharmaceutics11060272
Chicago/Turabian Style
Tunsirikongkon, Amolnat, Yong-Chul Pyo, Dong-Hyun Kim, Sang-Eun Lee, and Jeong-Sook Park.
2019. "Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug" Pharmaceutics 11, no. 6: 272.
https://doi.org/10.3390/pharmaceutics11060272
APA Style
Tunsirikongkon, A., Pyo, Y.-C., Kim, D.-H., Lee, S.-E., & Park, J.-S.
(2019). Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug. Pharmaceutics, 11(6), 272.
https://doi.org/10.3390/pharmaceutics11060272